OOIR: Observatory of International Research

Papers

(The H4-Index of npj Precision Oncology is 37. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Development and testing of a polygenic risk score for breast cancer aggressiveness	218
Retraction Note: Birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy	107
BRAF v600E–mutant cancers treated with vemurafenib alone or in combination with everolimus, sorafenib, or crizotinib or with paclitaxel and carboplatin (VEM-PLUS) study	101
Grading of lung adenocarcinomas with simultaneous segmentation by artificial intelligence (GLASS-AI)	95
Improved prediction of MAPKi response duration in melanoma patients using genomic data and machine learning	94
Author Correction: An automated deep learning pipeline for EMVI classification and response prediction of rectal cancer using baseline MRI: a multi-centre study	94
Patient-level proteomic network prediction by explainable artificial intelligence	92
Developing survival prediction models in colorectal cancer using epigenome-wide DNA methylation data from whole blood	90
Analyses of canine cancer mutations and treatment outcomes using real-world clinico-genomics data of 2119 dogs	84
Genome-wide analyses reveals an association between invasive urothelial carcinoma in the Shetland sheepdog and NIPAL1	74
Sub-regional radiomics combining multichannel 2-dimensional or 3-dimensional deep learning for predicting neoadjuvant chemo-immunotherapy response in esophageal squamous cell carcinoma: a multicenter	74
An automated deep learning pipeline for EMVI classification and response prediction of rectal cancer using baseline MRI: a multi-centre study	61
Circulating tumor DNA in ALK-positive anaplastic large cell lymphoma: a proof-of-concept study	59
Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlates	57
Tumor break load quantitates structural variant-associated genomic instability with biological and clinical relevance across cancers	54
Constitutional mismatch repair deficiency mimicking Lynch syndrome is associated with hypomorphic mismatch repair gene variants	53
Imaging and AI based chromatin biomarkers for diagnosis and therapy evaluation from liquid biopsies	51
The dynamic immune behavior of primary and metastatic ovarian carcinoma	50
Mucin-1: a promising pan-cancer therapeutic target	49
Complement activation in tumor microenvironment after neoadjuvant therapy and its impact on pancreatic cancer outcomes	49
Interferon signaling and ferroptosis in tumor immunology and therapy	49
A protein-encoding CCDC7 circular RNA inhibits the progression of prostate cancer by up-regulating FLRT3	48
Exosome- transported FER inhibitor suppresses progression of diffuse large B-cell lymphoma via regulating AJUBA/Hippo axis	47
Barriers and opportunities in pancreatic cancer immunotherapy	44
A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada	44

Co-targeting KRAS G12C and EGFR reduces both mutant and wild-type RAS-GTP	44
Enhanced efficacy of ipilimumab plus nivolumab in angiogenic subtypes of metastatic clear-cell renal cell carcinoma	43
Real-world experience of Molecular Tumour Boards for clinical decision-making for cancer patients	43
Erigoster B targeting DECR1 induces ferroptosis of breast cancer cells via promoting phosphatidylcholine/arachidonic acid metabolism	43
Histological transformation to gliosarcoma with combined BRAF/MEK inhibition in BRAF V600E mutated glioblastoma	43
Genomic and transcriptomic analyses identify distinctive features of triple-negative inflammatory breast cancer	41
Machine learning model for predicting tertiary lymphoid structures and treatment response in triple-negative breast cancer	40
TRIM65 regulates glucose metabolic reprogramming to promote glioma cell proliferation via ubiquitination and degradation of AMPK	40
Targeting Nrf2/PHKG2 axis to enhance radiosensitivity in NSCLC	39
Establishing predictive machine learning models for drug responses in patient derived cell culture	39
A universal immunohistochemistry analyzer for generalizing AI-driven assessment of immunohistochemistry across immunostains and cancer types	39
Stage-dependent spatial distribution and prognostic value of CD8+ tissue-resident memory T cells in NSCLC	37
Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab	37